220 related articles for article (PubMed ID: 10516332)
1. Methamphetamine-induced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat.
Wallace TL; Gudelsky GA; Vorhees CV
J Neurosci; 1999 Oct; 19(20):9141-8. PubMed ID: 10516332
[TBL] [Abstract][Full Text] [Related]
2. Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat.
Wallace TL; Gudelsky GA; Vorhees CV
Synapse; 2001 Jan; 39(1):1-7. PubMed ID: 11071703
[TBL] [Abstract][Full Text] [Related]
3. Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine.
Wallace TL; Gudelsky GA; Vorhees CV
Psychopharmacology (Berl); 2001 Jan; 153(3):321-6. PubMed ID: 11271404
[TBL] [Abstract][Full Text] [Related]
4. Caudate-putamen and nucleus accumbens extracellular acetylcholine responses to methamphetamine binges.
Kuczenski R; Segal DS
Brain Res; 2001 Dec; 923(1-2):32-8. PubMed ID: 11743969
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel antagonist isradipine attenuates cocaine-induced motor activity in rats: correlation with brain monoamine levels.
Mills K; Arsah TA; Ali SF; Shockley DC
Ann N Y Acad Sci; 1998 May; 844():201-7. PubMed ID: 9668678
[TBL] [Abstract][Full Text] [Related]
6. The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats.
Gehrke BJ; Harrod SB; Cass WA; Bardo MT
Psychopharmacology (Berl); 2003 Mar; 166(3):249-57. PubMed ID: 12589519
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions.
Zhang Y; Loonam TM; Noailles PA; Angulo JA
Ann N Y Acad Sci; 2001 Jun; 937():93-120. PubMed ID: 11458542
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo.
Sabol KE; Roach JT; Broom SL; Ferreira C; Preau MM
Brain Res; 2001 Feb; 892(1):122-9. PubMed ID: 11172757
[TBL] [Abstract][Full Text] [Related]
9. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization.
Segal DS; Kuczenski R
J Pharmacol Exp Ther; 1997 Aug; 282(2):561-73. PubMed ID: 9262316
[TBL] [Abstract][Full Text] [Related]
10. The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat.
Marek GJ; Vosmer G; Seiden LS
Brain Res; 1990 May; 516(1):1-7. PubMed ID: 2142010
[TBL] [Abstract][Full Text] [Related]
11. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
Abekawa T
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):113-26. PubMed ID: 9086367
[TBL] [Abstract][Full Text] [Related]
12. Effects of lubeluzole on the methamphetamine-induced increase in extracellular glutamate and the long-term depletion of striatal dopamine.
Wallace TL; Vorhees CV; Gudelsky GA
Synapse; 2001 May; 40(2):95-101. PubMed ID: 11252020
[TBL] [Abstract][Full Text] [Related]
13. Role of dopaminergic and GABAergic mechanisms in discrete brain areas in phencyclidine-induced locomotor stimulation and turning behavior.
Yamaguchi K; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 Dec; 9(12):975-86. PubMed ID: 3033192
[TBL] [Abstract][Full Text] [Related]
14. Effects of methamphetamine, dopamine and noradrenaline administered into the nucleus accumbens of rats discriminating subcutaneous methamphetamine.
Ando K; Miyata H; Yanagita T
Jpn J Pharmacol; 1994 Jan; 64(1):35-40. PubMed ID: 8164391
[TBL] [Abstract][Full Text] [Related]
15. 5-hydroxy-3-ethylamino-2-oxindole is not formed in rat brain following a neurotoxic dose of methamphetamine: evidence that methamphetamine does not induce the hydroxyl radical-mediated oxidation of serotonin.
Yang Z; Wrona MZ; Dryhurst G
J Neurochem; 1997 May; 68(5):1929-41. PubMed ID: 9109519
[TBL] [Abstract][Full Text] [Related]
16. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898
[TBL] [Abstract][Full Text] [Related]
17. Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats.
Narita M; Takagi M; Aoki K; Kuzumaki N; Suzuki T
J Neurochem; 2003 Jul; 86(2):273-82. PubMed ID: 12871568
[TBL] [Abstract][Full Text] [Related]
18. A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration.
Shankaran M; Gudelsky GA
Psychopharmacology (Berl); 1999 Nov; 147(1):66-72. PubMed ID: 10591870
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine-induced behavioral alterations following repeated administration of methamphetamine.
Yamanaka Y; Takano R; Egashira T
Jpn J Pharmacol; 1986 Jun; 41(2):147-54. PubMed ID: 3091891
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine-induced decrease in neural glucocorticoid receptors: relationship to monoamine levels.
Lowy MT; Novotney S
Brain Res; 1994 Feb; 638(1-2):175-81. PubMed ID: 8199858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
